VistaGen Therapeutics (VTGN) Cash flow

Compare

1,162 Followers

VistaGen Therapeutics Cash Flow

VTGN's free cash flow for Q3 2026 was $-17.57M. For the 2026 fiscal year, VTGN's free cash flow was decreased by $-16.41M and operating cash flow was $-17.63M. See a summary of the company’s cash flow.

Cash Flow	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Operating Cash Flow	$ -42.10M	$ -25.81M	$ -49.72M	$ -45.26M	$ -12.07M
Investing Cash Flow	$ -13.15M	$ -61.00K	$ -740.00K	$ -200.40K	$ -275.40K
Financing Cash Flow	$ 3.21M	$ 128.40M	$ -1.04M	$ 10.48M	$ 114.10M
End Cash Position	$ 67.13M	$ 119.17M	$ 16.64M	$ 68.14M	$ 103.11M
Free Cash Flow	$ -42.29M	$ -25.87M	$ -49.93M	$ -45.46M	$ -12.35M

Currency in USD